Application 090950
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPINASTINE HYDROCHLORIDE | EPINASTINE HYDROCHLORIDE | SOLUTION; OPHTHALMIC | 0.05% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EPINASTINE HYDROCHLORIDE | EPINASTINE HYDROCHLORIDE | Somerset Therapeutics, LLC | 0d4ee45c-e58f-4b7c-b389-898f5c27f54d | 2025-03-22 | Warnings, Adverse reactions | EPINASTINE HYDROCHLORIDE EPINASTINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.